Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
11200675
DOI
10.1007/bf02817445
Knihovny.cz E-resources
- MeSH
- Virus Activation MeSH
- Transcription, Genetic MeSH
- Herpes Simplex Virus Protein Vmw65 metabolism MeSH
- Herpes Simplex virology MeSH
- Virus Latency MeSH
- Humans MeSH
- Herpesvirus 1, Human genetics physiology MeSH
- Neurons metabolism virology MeSH
- Immediate-Early Proteins metabolism MeSH
- Trans-Activators metabolism MeSH
- Transcription Factors metabolism MeSH
- Ubiquitin-Protein Ligases MeSH
- Viral Proteins metabolism MeSH
- Viral Structural Proteins metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Herpes Simplex Virus Protein Vmw65 MeSH
- herpes simplex virus type 1 protein VP22 MeSH Browser
- herpes simplex virus, type 1 protein ICP4 MeSH Browser
- ICP27 protein, human herpesvirus 1 MeSH Browser
- ICP47 protein, Herpes simplex virus MeSH Browser
- Immediate-Early Proteins MeSH
- Trans-Activators MeSH
- Transcription Factors MeSH
- Ubiquitin-Protein Ligases MeSH
- Viral Proteins MeSH
- Viral Structural Proteins MeSH
- Vmw110 protein, Human herpesvirus 1 MeSH Browser
During the last decade, new data accumulated describing the early events during herpes simplex virus 1 (HSV-1) replication occurring before capsid formation and virion envelopment. The HSV virion carries its own specific transcription initiation factor (alpha-TIF), which functions together with other components of the cellular transcriptase complex to mediate virus-specific immediate early (IE) transcription. The virus-coded IE proteins are the transactivator and regulatory elements modulating early transcription and subsequent translation of nonstructural virus-coded proteins needed mainly for viral DNA synthesis and for the supply of corresponding nucleoside components. They also cooperate at the late transcription and translation of the virion (capsid, tegument and envelope) proteins. In addition, the transactivator IE proteins down-regulate their own transcription, while others facilitate viral mRNA processing or interfere with the presentation of newly synthesized virus antigens. Establishment of latency is closely related to the transcription of a separate category of transcripts, termed latency-associated (LAT). Formation of LATs occurs mainly in nondividing neurons which are metabolically less active and express lower levels of cellular transcription factors (nonpermissive cells). Expression of the stable non-spliced (2 kb), and especially of stable spliced (1.5 and 1.45 kb) LATs is a prerequisite for HSV reactivation. Different HSV genomes (from various HSV strains) do not undergo IE transcription at the same rate. Restricted IE transcription and the absence of viral DNA synthesis favors LAT formation and persistence of the silenced genome. Uneven levels of LAT expression and differences in the metabolic state of carrier neurons influence the reactivation competence. Under artificial or natural activation conditions, sufficient amounts of IE transactivator proteins and proteins promoting nucleoside metabolism are synthesized even in the absence of the viral alpha-TIF facilitating reactivation.
See more in PubMed
J Virol. 1987 Dec;61(12):3820-6 PubMed
J Virol. 1998 Aug;72(8):6888-92 PubMed
Cell. 1982 Dec;31(2 Pt 1):355-65 PubMed
Mol Cell Biol. 1997 Oct;17(10):6139-46 PubMed
J Gen Virol. 1998 Jan;79 ( Pt 1):117-24 PubMed
J Virol. 1999 May;73(5):3810-7 PubMed
J Virol. 1996 Aug;70(8):5255-65 PubMed
Nucleic Acids Res. 1990 Dec 11;18(23):6871-80 PubMed
J Virol. 1998 Feb;72(2):1177-85 PubMed
Lancet. 1976 Feb 21;1(7956):397-9 PubMed
J Virol. 1997 Aug;71(8):5885-93 PubMed
Acta Virol. 1998 Apr;42(2):103-18 PubMed
J Virol. 1994 Dec;68(12):8045-55 PubMed
Annu Rev Biochem. 1997;66:347-84 PubMed
J Virol. 1997 Sep;71(9):6850-62 PubMed
J Virol. 1998 Apr;72(4):3495-500 PubMed
Proc Natl Acad Sci U S A. 1981 Oct;78(10):6276-80 PubMed
Virus Genes. 1999;18(1):81-90 PubMed
EMBO J. 1989 Feb;8(2):505-11 PubMed
J Virol. 1997 Feb;71(2):1019-24 PubMed
J Virol. 1997 Mar;71(3):1757-65 PubMed
Prog Med Virol. 1992;39:76-115 PubMed
Biochem J. 1992 Jun 15;284 ( Pt 3):667-73 PubMed
J Virol. 1999 Nov;73(11):9456-67 PubMed
Nucleic Acids Res. 1996 Jun 15;24(12):2324-30 PubMed
Arch Virol. 1990;113(1-2):107-13 PubMed
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9056-60 PubMed
J Virol. 1999 Dec;73(12):9726-33 PubMed
J Virol. 1994 Nov;68(11):6871-82 PubMed
J Gen Virol. 1988 Jul;69 ( Pt 7):1531-74 PubMed
J Virol. 1998 Jul;72(7):5343-50 PubMed
J Virol. 1994 Apr;68(4):2239-52 PubMed
J Virol. 1995 Mar;69(3):1389-99 PubMed
J Virol. 1993 Dec;67(12):7201-14 PubMed
J Gen Virol. 1994 Oct;75 ( Pt 10):2691-8 PubMed
J Virol. 1982 Dec;44(3):939-49 PubMed
Mol Cell Biol. 1996 Aug;16(8):4404-13 PubMed
J Virol. 1999 May;73(5):4305-15 PubMed
J Virol. 1988 Nov;62(11):4307-20 PubMed
J Virol. 1994 Mar;68(3):1283-92 PubMed
J Virol. 1996 Mar;70(3):1931-40 PubMed
J Virol. 1992 May;66(5):2916-27 PubMed
Mol Cells. 1999 Jun 30;9(3):277-80 PubMed
J Virol. 1988 May;62(5):1832-5 PubMed
J Virol. 1999 Mar;73(3):2161-72 PubMed
Virology. 1993 Feb;192(2):687-91 PubMed
J Virol. 1991 Dec;65(12):6800-10 PubMed
EMBO J. 1996 Jul 1;15(13):3247-55 PubMed
Acta Virol. 1983 Sep;27(5):442-50 PubMed
J Gen Virol. 1992 May;73 ( Pt 5):1287-91 PubMed
J Virol. 1992 Apr;66(4):2157-69 PubMed
Cell. 1991 Feb 8;64(3):475-8 PubMed
J Virol. 1996 Aug;70(8):5384-94 PubMed
J Virol. 1996 Feb;70(2):976-84 PubMed
Nature. 1988 Oct 6;335(6190):563-4 PubMed
Arch Virol. 1994;137(3-4):209-28 PubMed
J Virol. 1993 Nov;67(11):6903-8 PubMed
Virology. 1992 Nov;191(1):1-8 PubMed
Nucleic Acids Res. 1986 Jan 24;14(2):929-43 PubMed
J Virol. 1996 Mar;70(3):2014-8 PubMed
J Virol. 1999 Jan;73(1):417-26 PubMed
J Virol. 1997 Feb;71(2):1547-57 PubMed
J Gen Virol. 1995 Feb;76 ( Pt 2):321-32 PubMed
Virus Genes. 1997;15(2):155-9 PubMed
J Virol. 1987 Apr;61(4):992-1001 PubMed
J Virol. 1986 Feb;57(2):446-55 PubMed
J Virol. 1997 Aug;71(8):5878-84 PubMed
Curr Eye Res. 1986 Mar;5(3):241-6 PubMed
Invest Ophthalmol Vis Sci. 1998 Sep;39(10):1847-53 PubMed
J Gen Virol. 1987 Jun;68 ( Pt 6):1761-5 PubMed
J Virol. 1997 Oct;71(10):7328-36 PubMed
J Gen Virol. 1998 Sep;79 ( Pt 9):2093-8 PubMed
Arch Virol. 1987;97(1-2):137-44 PubMed
Nucleic Acids Res. 1984 Feb 24;12(4):2061-79 PubMed
J Virol. 1996 Aug;70(8):5476-86 PubMed
J Virol. 1989 Jun;63(6):2861-5 PubMed
J Virol. 1990 Jul;64(7):3269-79 PubMed
J Gen Virol. 1994 Mar;75 ( Pt 3):647-50 PubMed
J Virol. 1991 Aug;65(8):4142-52 PubMed
J Virol. 1997 Sep;71(9):6777-85 PubMed
J Virol. 1998 Sep;72(9):7115-24 PubMed
Acta Virol. 1975 Jan;19(1):19-28 PubMed
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7122-6 PubMed
J Neurovirol. 1996 Aug;2(4):268-78 PubMed
J Virol. 1997 Dec;71(12):9188-97 PubMed
J Virol. 1988 May;62(5):1479-85 PubMed
J Virol. 1998 Nov;72(11):8525-31 PubMed
J Virol. 1997 Jul;71(7):5423-31 PubMed
Virus Genes. 1998;16(3):239-51 PubMed
Mol Cell Biol. 1995 Jul;15(7):3618-26 PubMed
J Virol. 1997 Jul;71(7):5268-76 PubMed
J Virol. 1996 May;70(5):2883-93 PubMed
J Gen Virol. 1990 Apr;71 ( Pt 4):953-7 PubMed
J Virol. 1989 Feb;63(2):943-7 PubMed
J Virol. 1996 May;70(5):3137-41 PubMed
Nature. 1986 Aug 14-20;322(6080):656-9 PubMed
J Virol. 1999 Apr;73(4):3246-57 PubMed
J Virol. 1998 Oct;72(10):7785-95 PubMed
Nature. 1995 Jun 1;375(6530):415-8 PubMed
Nat New Biol. 1972 Feb 16;235(59):216-7 PubMed
J Virol. 1991 May;65(5):2724-7 PubMed
J Virol. 1997 Jun;71(6):4614-25 PubMed
J Virol. 1998 Aug;72(8):6752-7 PubMed
Intervirology. 1991;32(2):76-92 PubMed
Genes Dev. 1991 Dec;5(12B):2555-66 PubMed
J Virol. 1999 Apr;73(4):3418-23 PubMed
J Virol. 1998 Jul;72(7):5626-37 PubMed
J Virol. 1988 Dec;62(12):4577-85 PubMed
Neuron. 1990 Feb;4(2):215-22 PubMed
J Virol. 1989 Sep;63(9):3844-51 PubMed
J Gen Virol. 1988 May;69 ( Pt 5):1079-83 PubMed
Virology. 1993 Aug;195(2):337-47 PubMed
J Virol. 1997 Oct;71(10):7807-13 PubMed
Mol Cell Biol. 1996 Jun;16(6):3085-93 PubMed
Cell. 1996 Nov 1;87(3):427-36 PubMed
J Virol. 1998 Aug;72(8):6581-91 PubMed
Bacteriol Rev. 1964 Dec;28:472-9 PubMed
J Virol. 1997 Sep;71(9):6714-9 PubMed
Virology. 1992 Jul;189(1):150-60 PubMed
J Virol. 1997 Nov;71(11):8602-14 PubMed
Annu Rev Biochem. 1992;61:419-40 PubMed
J Gen Virol. 1975 Sep;28(3):341-53 PubMed
J Virol. 1999 Aug;73(8):6618-25 PubMed
J Virol. 1999 Jul;73(7):5593-604 PubMed
J Virol. 1996 Sep;70(9):5962-7 PubMed
J Neurovirol. 1997 Jun;3(3):212-24 PubMed
J Virol. 1995 Nov;69(11):7187-95 PubMed
J Virol. 1996 Jan;70(1):282-91 PubMed
J Gen Virol. 1999 May;80 ( Pt 5):1271-1282 PubMed
Science. 1990 Nov 30;250(4985):1262-6 PubMed
Intervirology. 1991;32(2):101-15 PubMed
J Virol. 1996 Mar;70(3):1969-80 PubMed
Folia Microbiol (Praha). 1999;44(5):467-86 PubMed
J Virol. 1997 Aug;71(8):6083-93 PubMed
J Gen Virol. 1988 Jun;69 ( Pt 6):1147-56 PubMed
Virology. 1998 Jun 20;246(1):145-57 PubMed
Virology. 1999 May 10;257(2):341-51 PubMed
J Virol. 1995 Nov;69(11):7087-98 PubMed
J Virol. 1990 Jul;64(7):3417-26 PubMed
J Biol Chem. 1995 Sep 8;270(36):21312-8 PubMed
J Virol. 1994 Feb;68(2):823-33 PubMed
Virus Res. 1997 Jul;50(1):95-106 PubMed
Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10379-84 PubMed
Folia Microbiol (Praha). 1999;44(6):713-9 PubMed
J Virol. 1993 Oct;67(10):6125-35 PubMed
J Virol. 1999 Jan;73(1):650-7 PubMed
Proc Natl Acad Sci U S A. 1988 Sep;85(17):6347-51 PubMed
J Virol. 1998 Jun;72(6):5067-75 PubMed
Microb Pathog. 1989 Aug;7(2):121-34 PubMed
Invest Ophthalmol Vis Sci. 1981 Sep;21(3):442-9 PubMed
J Virol. 1998 Jul;72(7):5373-82 PubMed
Nature. 1983 Apr 7;302(5908):523-5 PubMed
J Virol. 1990 Jul;64(7):3471-85 PubMed
J Gen Virol. 2000 Jan;81(Pt 1):1-19 PubMed
J Virol. 1994 Mar;68(3):1271-82 PubMed
Virology. 1995 Feb 20;207(1):107-16 PubMed
J Virol. 1990 Apr;64(4):1704-15 PubMed
J Virol. 1997 Sep;71(9):7039-47 PubMed
Nature. 1995 Jun 1;375(6530):411-5 PubMed
J Virol. 1992 May;66(5):2904-15 PubMed
J Virol. 1990 Nov;64(11):5396-402 PubMed
J Virol. 1992 Jan;66(1):341-8 PubMed
Prevention of infection transmission during stem cell transplantation
Developments in herpes simplex virus vaccines: old problems and new challenges